Exocrine Pancreatic Insufficiency Differential Diagnoses

1. Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency - breaking the myths. BMC Med. 2017 Feb 10. 15 (1):29. [QxMD MEDLINE Link]. [Full Text].

2. Perbtani Y, Forsmark CE. Update on the diagnosis and management of exocrine pancreatic insufficiency. F1000Res. 2019. 8:[QxMD MEDLINE Link]. [Full Text].

3. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005 Jul. 54 Suppl 6:vi1-28. [QxMD MEDLINE Link]. [Full Text].

4. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973 Apr 19. 288(16):813-5. [QxMD MEDLINE Link].

5. Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011. 4:55-73. [QxMD MEDLINE Link]. [Full Text].

6. Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol. 2011 May 31. 8(7):405-15. [QxMD MEDLINE Link].

7. Shandro BM, Nagarajah R, Poullis A. Challenges in the management of pancreatic exocrine insufficiency. World J Gastrointest Pharmacol Ther. 2018 Oct 25. 9 (5):39-46. [QxMD MEDLINE Link]. [Full Text].

8. Ferrone M, Raimondo M, Scolapio JS. Pancreatic enzyme pharmacotherapy. Pharmacotherapy. 2007 Jun. 27(6):910-20. [QxMD MEDLINE Link].

9. Krishnamurty DM, Rabiee A, Jagannath SB, Andersen DK. Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis. Ther Clin Risk Manag. 2009 Jun. 5(3):507-20. [QxMD MEDLINE Link]. [Full Text].

10. Bruno MJ, Rauws EA, Hoek FJ, Tytgat GN. Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy. Dig Dis Sci. 1994 May. 39(5):988-92. [QxMD MEDLINE Link].

11. Mizushima T, Ochi K, Ichimura M, Kiura K, Harada H, Koide N. Pancreatic enzyme supplement improves dysmotility in chronic pancreatitis patients. J Gastroenterol Hepatol. 2004 Sep. 19(9):1005-9. [QxMD MEDLINE Link].

12. Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep. 2007 Apr. 9(2):116-22. [QxMD MEDLINE Link].

13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003 Jan. 26 Suppl 1:S5-20. [QxMD MEDLINE Link].

14. Huang W, de la Iglesia-Garcia D, Baston-Rey I, et al. Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis. Dig Dis Sci. 2019 Jul. 64 (7):1985-2005. [QxMD MEDLINE Link]. [Full Text].

15. Sanklecha M, Balani K. Chronic pancreatic insufficiency-think of Shwachmann Diamond Syndrome. Indian Pediatr. 2012 May. 49(5):417-8. [QxMD MEDLINE Link].

16. Nelson A, Myers K, Adam MP, et al. Shwachman-Diamond Syndrome. 2008 Jul 17 [updated 2018 Oct 18]. [QxMD MEDLINE Link]. [Full Text].

17. Yatchenko Y, Horwitz A, Birk R. Endocrine and exocrine pancreas pathologies crosstalk: Insulin regulates the unfolded protein response in pancreatic exocrine acinar cells. Exp Cell Res. 2019 Jan 6. [QxMD MEDLINE Link].

18. Sah RP, Chari ST. Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management. Curr Gastroenterol Rep. 2012 Apr. 14(2):95-105. [QxMD MEDLINE Link].

19. Ali S, T N, Gagloo M, Dhar S. Revisiting the problem of pancreatic exocrine insufficiency in surgical patients. Internet J Surg. 2012. 28(2):[Full Text].

20. Huddy JR, Macharg FM, Lawn AM, Preston SR. Exocrine pancreatic insufficiency following esophagectomy. Dis Esophagus. 2012 Nov 30. [QxMD MEDLINE Link].

21. Dhar VK, Levinsky NC, Xia BT, et al. The natural history of chronic pancreatitis after operative intervention: The need for revisional operation. Surgery. 2016 Jul 20. [QxMD MEDLINE Link].

22. Okano K, Murakami Y, Nakagawa N, et al. Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy. Surgery. 2016 Mar. 159 (3):885-92. [QxMD MEDLINE Link].

23. Hallac A, Aleassa EM, Rogers M, Falk GA, Morris-Stiff G. Exocrine pancreatic insufficiency in distal pancreatectomy: incidence and risk factors. HPB (Oxford). 2019 Jul 18. [QxMD MEDLINE Link].

24. Lowenfels AB, Sullivan T, Fiorianti J, Maisonneuve P. The epidemiology and impact of pancreatic diseases in the United States. Curr Gastroenterol Rep. 2005 May. 7(2):90-5. [QxMD MEDLINE Link].

25. de la Iglesia D, Vallejo-Senra N, Lopez-Lopez A, et al. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: a prospective, longitudinal cohort study. J Gastroenterol Hepatol. 2018 Aug 29. [QxMD MEDLINE Link].

26. Vujasinovic M, Dugic A, Thiel T, Kjellman A, Yang C, Lohr JM. Pancreatic exocrine insufficiency is a risk factor for kidney stones in patients with chronic pancreatitis. Pancreatology. 2023 Apr. 23 (3):294-8. [QxMD MEDLINE Link].

27. Lindkvist B, Dominguez-Munoz JE, Luaces-Regueira M, Castineiras-Alvarino M, Nieto-Garcia L, Iglesias-Garcia J. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012 Jul-Aug. 12(4):305-10. [QxMD MEDLINE Link].

28. Ghoshal UC, Kumar S, Chourasia D, Misra A. Lactose hydrogen breath test versus lactose tolerance test in the tropics: does positive lactose tolerance test reflect more severe lactose malabsorption?. Trop Gastroenterol. 2009 Apr-Jun. 30(2):86-90. [QxMD MEDLINE Link].

29. Casterton PL, Verbeke KA, Brouns F, Dammann KW. Evaluation of sucromalt digestion in healthy children using breath hydrogen as a biomarker of carbohydrate malabsorption. Food Funct. 2012 Apr. 3(4):410-3. [QxMD MEDLINE Link].

30. Hope HB, Tveito K, Aase S, Messelt E, Utzon P, Skar V. Small intestinal malabsorption in chronic alcoholism determined by 13C-D-xylose breath test and microscopic examination of the duodenal mucosa. Scand J Gastroenterol. 2010. 45(1):39-45. [QxMD MEDLINE Link].

31. Chowdhury RS, Forsmark CE. Review article: Pancreatic function testing. Aliment Pharmacol Ther. 2003 Mar 15. 17(6):733-50. [QxMD MEDLINE Link].

32. Hammer HF. Pancreatic exocrine insufficiency: diagnostic evaluation and replacement therapy with pancreatic enzymes. Dig Dis. 2010. 28(2):339-43. [QxMD MEDLINE Link].

33. Gonzalez-Sanchez V, Amrani R, Gonzalez V, Trigo C, Pico A, de-Madaria E. Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: ¹³C-Mixed Triglyceride Breath Test versus Fecal Elastase. Pancreatology. 2017 Mar 6. [QxMD MEDLINE Link].

34. Saad M, Vitale DS, Lin TK, et al. Image or scope: magnetic resonance imaging and endoscopic testing for exocrine and endocrine pancreatic insufficiency in children. Pancreatology. 2023 Apr 16. [QxMD MEDLINE Link].

35. Sankararaman S, Schindler T, Sferra TJ. Management of Exocrine Pancreatic Insufficiency in Children. Nutr Clin Pract. 2019 Oct. 34 Suppl 1:S27-S42. [QxMD MEDLINE Link]. [Full Text].

36. Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011. 4:55-73. [QxMD MEDLINE Link]. [Full Text].

37. Dominguez-Munoz JE. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?. Adv Med Sci. 2011. 56(1):1-5. [QxMD MEDLINE Link].

38. de la Iglesia-Garcia D, Huang W, Szatmary P, et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut. 2016 Dec 9. [QxMD MEDLINE Link]. [Full Text].

39. Erchinger F, Ovre AKN, Aarseth MM, et al. Fecal fat and energy loss in pancreas exocrine insufficiency: the role of pancreas enzyme replacement therapy. Scand J Gastroenterol. 2018 Sep 7. 1-7. [QxMD MEDLINE Link].

40. Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol. 2010 Oct. 105(10):2276-86. [QxMD MEDLINE Link].

41. Gubergrits N, Malecka-Panas E, Lehman GA, Vasileva G, Shen Y, Sander-Struckmeier S, et al. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther. 2011 May. 33(10):1152-61. [QxMD MEDLINE Link].

42. Toskes PP, Secci A, Thieroff-Ekerdt R. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis. Pancreas. 2011 Apr. 40(3):376-82. [QxMD MEDLINE Link].

43. Trapnell BC, Strausbaugh SD, Woo MS, et al. Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2011 Sep. 10(5):350-6. [QxMD MEDLINE Link].

44. Jablonska B. Is endoscopic therapy the treatment of choice in all patients with chronic pancreatitis?. World J Gastroenterol. 2013 Jan 7. 19(1):12-6. [QxMD MEDLINE Link]. [Full Text].

45. Borowitz D, Stevens C, Brettman LR, Campion M, Wilschanski M, Thompson H. Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis. J Pediatr Gastroenterol Nutr. 2012 Feb. 54(2):248-57. [QxMD MEDLINE Link].

46. Phillips ME, Hopper AD, Leeds JS, et al. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterol. 2021 Jun. 8 (1):[QxMD MEDLINE Link].

47. Karnik NP, Jan A. Pancrelipase. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].

48. Venkatesh P, Kasi A. Pancrelipase Therapy. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].

Samer Al-Kaade, MD Physician, Mercy Clinic Gastroenterology

Samer Al-Kaade, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, American Pancreatic Association

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Abbvie.

Romesh Khardori, MD, PhD, FACP (Retired) Professor, Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Eastern Virginia Medical School

Romesh Khardori, MD, PhD, FACP is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Physicians, American Diabetes Association, Endocrine Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article